STARRETT (L.S.) CO -CL A (SCX)

US8556681091 - Common Stock

16.02  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SCX. SCX was compared to 132 industry peers in the Machinery industry. SCX has an excellent financial health rating, but there are some minor concerns on its profitability. SCX has a valuation in line with the averages, but on the other hand it scores bad on growth.



6

1. Profitability

1.1 Basic Checks

In the past year SCX was profitable.
SCX had a positive operating cash flow in the past year.
SCX had positive earnings in 4 of the past 5 years.
SCX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

SCX's Return On Assets of 10.38% is amongst the best of the industry. SCX outperforms 82.95% of its industry peers.
With a decent Return On Equity value of 14.81%, SCX is doing good in the industry, outperforming 68.22% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.46%, SCX is in line with its industry, outperforming 58.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SCX is in line with the industry average of 10.72%.
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROIC 7.46%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%

1.3 Margins

SCX's Profit Margin of 7.72% is fine compared to the rest of the industry. SCX outperforms 62.79% of its industry peers.
SCX has a Operating Margin (5.64%) which is in line with its industry peers.
SCX's Operating Margin has improved in the last couple of years.
SCX has a better Gross Margin (31.48%) than 60.47% of its industry peers.
In the last couple of years the Gross Margin of SCX has remained more or less at the same level.
Industry RankSector Rank
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SCX is creating some value.
Compared to 1 year ago, SCX has more shares outstanding
Compared to 5 years ago, SCX has more shares outstanding
The debt/assets ratio for SCX has been reduced compared to a year ago.

2.2 Solvency

SCX has an Altman-Z score of 4.32. This indicates that SCX is financially healthy and has little risk of bankruptcy at the moment.
SCX's Altman-Z score of 4.32 is fine compared to the rest of the industry. SCX outperforms 72.87% of its industry peers.
SCX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
The Debt to FCF ratio of SCX (0.50) is better than 90.70% of its industry peers.
SCX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.02, SCX belongs to the best of the industry, outperforming 82.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Altman-Z 4.32
ROIC/WACC0.8
WACC9.34%

2.3 Liquidity

A Current Ratio of 3.11 indicates that SCX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.11, SCX is in the better half of the industry, outperforming 75.19% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that SCX should not have too much problems paying its short term obligations.
SCX has a better Quick ratio (1.42) than 65.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.42

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.20% over the past year.
Looking at the last year, SCX shows a decrease in Revenue. The Revenue has decreased by -2.50% in the last year.
Measured over the past years, SCX shows a small growth in Revenue. The Revenue has been growing by 3.44% on average per year.
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-112.51%
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Revenue growth Q2Q-7.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.26 indicates a rather cheap valuation of SCX.
Based on the Price/Earnings ratio, SCX is valued cheaper than 97.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.84. SCX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.26
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCX indicates a rather cheap valuation: SCX is cheaper than 90.70% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCX indicates a rather cheap valuation: SCX is cheaper than 96.12% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.65
EV/EBITDA 6.34

4.3 Compensation for Growth

The decent profitability rating of SCX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SCX!.
Industry RankSector Rank
Dividend Yield N/A

STARRETT (L.S.) CO -CL A

NYSE:SCX (4/26/2024, 7:15:25 PM)

16.02

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap128.96M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.26
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.11
Quick Ratio 1.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y